Gwenn Hansen sold $37K of Nurix Therapeutics, Inc. (NRIX) stock

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 1,452 shares of NRIX stock worth $37K, per an SEC Form 4 filed Sep 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 1, 2026.

NRIX has moved -2.4% since the trade date, from $26.04 to $25.41 (Sep 21, 2026 close).